| Members |
targetComponentId |
| Corynebacterium flaccumfaciens |
Curtobacterium flaccumfaciens (organism) |
| Corynebacterium flaccumfaciens subsp betae |
Curtobacterium flaccumfaciens (organism) |
| Corynebacterium flaccumfaciens subsp oortii |
Curtobacterium flaccumfaciens (organism) |
| Corynebacterium flaccumfaciens subsp poinsettiae |
Curtobacterium flaccumfaciens (organism) |
| Corynebacterium liquefaciens |
Brevibacterium liquefaciens |
| Corynebacterium nigricans |
Corynebacterium aurimucosum (organism) |
| Corynebacterium paurometabolum |
Tsukamurella paurometabola (organism) |
| Corynebacterium vitarumen |
Corynebacterium vitaeruminis (organism) |
| Count of active ingredient |
Count of active ingredient (attribute) |
| räkning av bas- och modifieringspar |
Count of base and modification pair (attribute) |
| räkning av bas i aktiv ingrediens |
Count of base of active ingredient |
| antal läkemedelstyper |
Count of clinical drug type (attribute) |
| biverkning av hudretande avledande medel |
Adverse reaction to drug |
| Course |
Clinical course |
| Cowdria |
Ehrlichia |
| Cowdria ruminantium |
Ehrlichia ruminantium (organism) |
| koxartrolistetiskt bäcken |
Coxitis (disorder) |
| krabba, livsmedel |
Crab (substance) |
| kraniell manipulation |
Osteopathic cranial manipulative medicine (procedure) |
| Craniectomy, trephination, bone flap craniotomy for coagulation of choroid plexus |
Craniectomy |
| Craniectomy, trephination, bone flap craniotomy for total hemispherectomy |
Spinal cordotomy |
| Craniofenestria |
Craniolacunia |
| kraniosakral manipulation |
Osteopathic cranial manipulative medicine (procedure) |
| syndrom med kraniosynostos med ansiktsmissbildning och brakydaktyli |
Fibroblast growth factor receptor 3-related craniosynostosis (disorder) |
| Crax mitu |
Mitu mitu (organism) |
| kräfta, livsmedel |
Crayfish (substance) |
| Creation of arterioarterial bypass |
Arterial bypass graft |
| Creation of lesion of spinal cord by any modality |
Spinal cord destructive procedure |
| anläggande av oleotorax |
Procedure on thorax |
| krimfeber |
Congo-Crimean hemorrhagic fever (disorder) |
| allergi mot kromoglykat och relaterade antiallergikum |
Allergy to cromoglicic acid (finding) |
| natriumkromoglikat 0,8 mg/dos |
Sodium cromoglicate 800 microgram/actuation powder for inhalation |
| natriumkromoglikat 8,1 g, sprej |
Sodium cromoglicate 800 microgram/actuation powder for inhalation |
| tvärbunden hyaluronsyra 24 mg/ml, gel för injektion |
Hyaluronic acid only product in parenteral dose form |
| längd från hjässa till häl |
Recumbent body height (observable entity) |
| metallkeramisk krona i högädelmetallegering |
Restoration of tooth using porcelain fused to noble metal crown |
| metallkeramisk krona i ädelmetallegering |
Restoration of tooth using porcelain fused to noble metal crown |
| grymhet |
Cruel behavior |
| Crushing injury of multiple sites of shoulder AND/OR upper arm (disorder) |
Crushing injury of multiple sites of upper limb |
| Crushing injury of multiple sites, NEC |
Crushing injury of multiple sites |
| Crustacean |
Subphylum Crustacea (organism) |
| Cryotherapy to lesion of organ NOC |
Cryotherapy |
| Cryotherapy to organ NOC |
Cryotherapy |
| Cryotherapy to organ NOC NOS |
Cryotherapy |
| Cryotherapy to organ NOC OS |
Cryotherapy |
| Cryptococcus albidus, variant albidus |
Naganishia albida (organism) |
| Cryptococcus antigen level |
Cryptococcus species antigen assay |
| Cryptococcus antigen level |
Cryptococcus species antigen assay |
| mätning av kryptokockantigen |
Cryptococcus species antigen assay |
| Cryptococcus neoformans, varietet gattii |
Cryptococcus gattii (organism) |
| Cryptogenic |
Unknown (origin) |
| kryptogen generaliserad epilepsi |
Generalized epilepsy |
| kryptogen myoklonusepilepsi |
Generalized epilepsy |
| Crystal arthropathy of other site |
Crystal arthropathy |
| kristallviolett tatuering |
Crystal violet tattoo |
| Crystalline lens and capsule |
Eye part |
| gurka, livsmedel |
Cucumber (substance) |
| Cucumovirus group |
Genus Cucumovirus (organism) |
| Curettage of lesion of organ NOC |
Curettage |
| Curettage of organ NOC |
Curettage |
| Curettage of organ NOC NOS |
Curettage |
| Curettage of organ NOC OS |
Curettage |
| Curettage of products of conception from uterus NEC |
Dilation of cervix uteri and curettage of products of conception from uterus |
| Curettage products conception: [uterus NEC (& retained)] or [termination NEC] |
Dilation of cervix uteri and curettage of products of conception from uterus |
| Curling esophagus |
Diffuse spasm of esophagus |
| Curvature of stomach |
Stomach part |
| kutan CD30-positiv lymfoproliferativ sjukdom |
Primary cutaneous CD30+ large T-cell lymphoma |
| kutant T-cellslymfom |
Cutaneous T-cell lymphoma |
| Cutaneous anaphylaxis |
Localized anaphylaxis |
| kutan eruption |
Eruption |
| cyanokobalamin 25 mikrogram, nässprej |
Product containing only cyanocobalamin in nasal dose form (medicinal product form) |
| cyanokobalamin 500 mikrogram, nässprej |
Cyanocobalamin 500 microgram/actuation nasal spray |
| cyankobolamin (^57^Co) 370 kBq/ml, oral lösning |
Cyanocobalamin (57-Co) only product in oral dose form |
| cyankobolamin (^58^Co) 370 kBq/ml, oral lösning |
Product containing only cyanocobalamin (58-Co) in oral dose form (medicinal product form) |
| CyberKnife |
Robotic radiation delivery system |
| cykliskt ödem |
Edema |
| cykloanemisering |
Destruction of ciliary body |
| Cyclopentolate hydrochloride + phenylephrine hydrochloride |
Product containing cyclopentolate and phenylephrine (medicinal product) |
| cyklopentolathydroklorid 0,5 %, ögondroppar |
Cyclopentolate hydrochloride 5 mg/mL eye solution |
| cyklopentolathydroklorid 0,5 %, ögondroppar för engångsbruk |
Cyclopentolate hydrochloride 5 mg/mL eye solution |
| cyklopentolathydroklorid 1 %, ögondroppar |
Cyclopentolate hydrochloride 10 mg/mL eye solution |
| cyklopentolathydroklorid 1 %, ögondroppar för engångsbruk |
Cyclopentolate hydrochloride 10 mg/mL eye solution |
| cyklopentolathydroklorid 2 %, ögondroppar |
Cyclopentolate hydrochloride 20 mg/mL eye solution |
| Cyclophosphamide 1g/vial injection |
Cyclophosphamide 1 g powder for solution for injection vial |
| Cyclophosphamide 1g/vial powder for injection |
Cyclophosphamide 1 g powder for solution for injection vial |
| Cyclophosphamide 200mg/vial injection |
Cyclophosphamide 200 mg powder for solution for injection vial |
| Cyclophosphamide 200mg/vial powder for injection |
Cyclophosphamide 200 mg powder for solution for injection vial |
| Cyclophosphamide 2g/vial injection |
Product containing precisely cyclophosphamide 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Cyclophosphamide 500mg/vial injection |
Cyclophosphamide 500 mg powder for solution for injection vial |
| Cyclophosphamide 500mg/vial powder for injection |
Cyclophosphamide 500 mg powder for solution for injection vial |
| Cyclopropane [no agents] |
Cyclopropane |
| cyklosporin 50 mg/ml, oljehaltigt infusionskoncentrat |
Product containing precisely ciclosporin 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| cyklosporin 100 mg/5 ml, lösning |
Product containing only ciclosporin (medicinal product) |
| cyklosporin 100 mg/ml, lösning |
Ciclosporin 100 mg/mL oral solution |
| Cyclosporine 50mg gel |
Ciclosporin 50 mg oral capsule |
| cyklosporin 0,05 %, emulsion för oftalmiskt bruk |
Product containing precisely ciclosporin 500 microgram/1 milliliter conventional release eye suspension (clinical drug) |
| papillom i cylinderepitel, oklart om benignt eller malignt |
Oncocytic Schneiderian papilloma of uncertain behavior (morphologic abnormality) |
| Cylindrocarpon tonkinense |
Cylindrocarpon lichenicola |
| cyproheptadinhydroklorid 2 mg/5 ml, oral sirap |
Product containing precisely cyproheptadine hydrochloride 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
| Cyriax's syndrome |
Tietze's disease (disorder) |
| Cyst of Bartholin's gland |
Cyst of Bartholin's gland duct |
FHIR